Cargando…

Paediatric anaphylaxis in South Africa

INTRODUCTION: Anaphylaxis is a severe, life-threatening generalized hypersensitivity reaction. While guidelines to reduce the morbidity, risk, and mortality of anaphylaxis are widely available, adherence to these is often suboptimal. We aimed to audit paediatric anaphylaxis at a South African tertia...

Descripción completa

Detalles Bibliográficos
Autores principales: Chippendale, Sa-eeda, Reichmuth, Kirsten, Worm, Margitta, Levin, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478922/
https://www.ncbi.nlm.nih.gov/pubmed/36185548
http://dx.doi.org/10.1016/j.waojou.2022.100666
_version_ 1784790680339480576
author Chippendale, Sa-eeda
Reichmuth, Kirsten
Worm, Margitta
Levin, Michael
author_facet Chippendale, Sa-eeda
Reichmuth, Kirsten
Worm, Margitta
Levin, Michael
author_sort Chippendale, Sa-eeda
collection PubMed
description INTRODUCTION: Anaphylaxis is a severe, life-threatening generalized hypersensitivity reaction. While guidelines to reduce the morbidity, risk, and mortality of anaphylaxis are widely available, adherence to these is often suboptimal. We aimed to audit paediatric anaphylaxis at a South African tertiary allergy referral centre, comparing our data to those of the large Network of Severe Allergic Reactions (NORA) registry. METHODS: Children treated for severe allergic reactions between January 2014 and August 2016 were identified for screening using ICD-10 coding of all admissions and discharges, pharmacy records of adrenaline autoinjector dispensing, and additional referrals from the allergy department to the study. Screened participants not meeting the inclusion criteria after preliminary questioning and/or folder review were excluded. Data were collected via a standardized questionnaire using direct interviews, and captured on a local web-based registry. RESULTS: Of the 156 episodes analysed, >40% were graded as severe and nearly two-thirds of patients were seen for a recurrent episode. Males, younger children, and individuals of mixed-race ethnicity were more frequently affected. Skin and mucosa were most commonly involved, followed by respiratory and gastrointestinal involvement; cardiovascular and other systemic involvement occurred infrequently. Specific IgE assay was the most frequently requested test. Food-related triggers (peanut, hen's egg, fish, cashew nuts and cows' milk) predominated and decreased with age. Anaphylaxis was strongly correlated with atopic conditions. While prophylactic measures were almost universally instituted, adrenaline was rarely used, by both lay persons and healthcare professionals. Hospital admissions were infrequent, and no deaths were recorded. CONCLUSION: Management of anaphylaxis can be improved. Specifically, the use of adrenaline prior to hospital arrival remains suboptimal. Ongoing education and training of patients, parents, teachers, and healthcare workers is identified as an area requiring intensification.
format Online
Article
Text
id pubmed-9478922
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher World Allergy Organization
record_format MEDLINE/PubMed
spelling pubmed-94789222022-09-30 Paediatric anaphylaxis in South Africa Chippendale, Sa-eeda Reichmuth, Kirsten Worm, Margitta Levin, Michael World Allergy Organ J Full-Length Article INTRODUCTION: Anaphylaxis is a severe, life-threatening generalized hypersensitivity reaction. While guidelines to reduce the morbidity, risk, and mortality of anaphylaxis are widely available, adherence to these is often suboptimal. We aimed to audit paediatric anaphylaxis at a South African tertiary allergy referral centre, comparing our data to those of the large Network of Severe Allergic Reactions (NORA) registry. METHODS: Children treated for severe allergic reactions between January 2014 and August 2016 were identified for screening using ICD-10 coding of all admissions and discharges, pharmacy records of adrenaline autoinjector dispensing, and additional referrals from the allergy department to the study. Screened participants not meeting the inclusion criteria after preliminary questioning and/or folder review were excluded. Data were collected via a standardized questionnaire using direct interviews, and captured on a local web-based registry. RESULTS: Of the 156 episodes analysed, >40% were graded as severe and nearly two-thirds of patients were seen for a recurrent episode. Males, younger children, and individuals of mixed-race ethnicity were more frequently affected. Skin and mucosa were most commonly involved, followed by respiratory and gastrointestinal involvement; cardiovascular and other systemic involvement occurred infrequently. Specific IgE assay was the most frequently requested test. Food-related triggers (peanut, hen's egg, fish, cashew nuts and cows' milk) predominated and decreased with age. Anaphylaxis was strongly correlated with atopic conditions. While prophylactic measures were almost universally instituted, adrenaline was rarely used, by both lay persons and healthcare professionals. Hospital admissions were infrequent, and no deaths were recorded. CONCLUSION: Management of anaphylaxis can be improved. Specifically, the use of adrenaline prior to hospital arrival remains suboptimal. Ongoing education and training of patients, parents, teachers, and healthcare workers is identified as an area requiring intensification. World Allergy Organization 2022-09-12 /pmc/articles/PMC9478922/ /pubmed/36185548 http://dx.doi.org/10.1016/j.waojou.2022.100666 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Full-Length Article
Chippendale, Sa-eeda
Reichmuth, Kirsten
Worm, Margitta
Levin, Michael
Paediatric anaphylaxis in South Africa
title Paediatric anaphylaxis in South Africa
title_full Paediatric anaphylaxis in South Africa
title_fullStr Paediatric anaphylaxis in South Africa
title_full_unstemmed Paediatric anaphylaxis in South Africa
title_short Paediatric anaphylaxis in South Africa
title_sort paediatric anaphylaxis in south africa
topic Full-Length Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478922/
https://www.ncbi.nlm.nih.gov/pubmed/36185548
http://dx.doi.org/10.1016/j.waojou.2022.100666
work_keys_str_mv AT chippendalesaeeda paediatricanaphylaxisinsouthafrica
AT reichmuthkirsten paediatricanaphylaxisinsouthafrica
AT wormmargitta paediatricanaphylaxisinsouthafrica
AT levinmichael paediatricanaphylaxisinsouthafrica